These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

164 related articles for article (PubMed ID: 2197242)

  • 1. Malignant mixed müllerian tumor of the ovary with prominent neuroectodermal differentiation (teratoid carcinosarcoma).
    Ehrmann RL; Weidner N; Welch WR; Gleiberman I
    Int J Gynecol Pathol; 1990; 9(3):272-82. PubMed ID: 2197242
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Malignant mixed müllerian tumor with malignant neuroectodermal components (teratoid carcinosarcoma) of the ovary: Report of a case with clinicopathologic findings.
    Matsuura Y; Kitajima M; Hachisuga T; Tanimoto A; Okura N; Kihara I
    J Obstet Gynaecol Res; 2010 Aug; 36(4):907-11. PubMed ID: 20666968
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Teratoid carcinosarcoma of the ovary with prominent neuroectodermal differentiation.
    Tanimoto A; Arima N; Hayashi R; Hamada T; Matsuki Y; Sasaguri Y
    Pathol Int; 2001 Oct; 51(10):829-32. PubMed ID: 11881739
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Malignant Müllerian mixed tumor of the ovary associated with yolk sac tumor, neuroepithelial and trophoblastic differentiation (teratoid carcinosarcoma).
    García-Galvis OF; Cabrera-Ozoria C; Fernández JA; Stolnicu S; Nogales FF
    Int J Gynecol Pathol; 2008 Oct; 27(4):515-20. PubMed ID: 18753971
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Carcinosarcoma arising from high-grade serous carcinoma of the ovary without estrogen receptor, WT-1, and PAX8 immunoreactivity.
    Harada N; Nobuhara I; Haruta N; Higashiura Y; Fujii H; Yamao K; Shimada K
    Taiwan J Obstet Gynecol; 2022 Jan; 61(1):110-114. PubMed ID: 35181017
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Malignant ovarian tumor composed of endometrioid adenocarcinoma, clear cell adenocarcinoma, squamous cell carcinoma, yolk sac tumor and immature teratoma with prominent neuroectodermal and rhabdomyosarcomatous differentiation: a case study.
    Ohishi Y; Kaku T; Kaneki E; Wake N; Tsuneyoshi M
    Gynecol Oncol; 2007 May; 105(2):548-52. PubMed ID: 17341430
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Malignant mixed Müllerian tumor (homologous type) of the adnexa with neuroendocrine differentiation: a case report.
    Lim SC; Kim DC; Suh CH; Kee KH; Choi SJ
    J Korean Med Sci; 1998 Apr; 13(2):207-10. PubMed ID: 9610624
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Carcinoma (malignant mixed müllerian [mesodermal] tumor) of the uterus and ovary. Correlation of clinical, pathologic, and immunohistochemical features in 29 cases.
    Costa MJ; Khan R; Judd R
    Arch Pathol Lab Med; 1991 Jun; 115(6):583-90. PubMed ID: 1710102
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Germ cell tumors of the gonads: a selective review emphasizing problems in differential diagnosis, newly appreciated, and controversial issues.
    Ulbright TM
    Mod Pathol; 2005 Feb; 18 Suppl 2():S61-79. PubMed ID: 15761467
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Ovarian carcinosarcoma associated with bilateral tubal intraepithelial carcinoma: a case report.
    Brustmann H
    Int J Gynecol Pathol; 2013 Jul; 32(4):384-9. PubMed ID: 23722511
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Malignant mixed Müllerian tumour of the ovary with probable prognostic factors.
    Chandra S; Gaur DS; Chandra H; Saini S; Pathak VP
    J Obstet Gynaecol; 2011 Jul; 31(5):457-8. PubMed ID: 21627442
    [No Abstract]   [Full Text] [Related]  

  • 12. [SURGICAL TREATMENT OF OVARIAN CARCINOSARCOMA THAT DEVELOPED IN GIANT CYSTIC TERATOMA].
    Skyba VV; Hychka SH; Ivanko OV; Kuzyk PV; Lysytsia VV
    Klin Khir; 2016 Feb; (2):77-8. PubMed ID: 27244929
    [No Abstract]   [Full Text] [Related]  

  • 13. Malignant melanoma arising in an ovarian carcinosarcoma: case report and review of the literature.
    Roma AA; Malpica A; Deavers MT
    Int J Gynecol Pathol; 2011 Mar; 30(2):158-62. PubMed ID: 21293284
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Extragenital malignant mixed müllerian tumor.
    Chen KT; Wolk RW
    Gynecol Oncol; 1988 Jul; 30(3):422-6. PubMed ID: 2839396
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Carcinosarcoma of the ovary a review.
    Cantrell LA; Van Le L
    Obstet Gynecol Surv; 2009 Oct; 64(10):673-80; quiz 697. PubMed ID: 19772676
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A rare case of ovarian carcinosarcoma with squamous cell carcinoma.
    Daimon A; Fujiwara S; Tanaka Y; Tanaka T; Ohmichi M
    J Ovarian Res; 2019 Apr; 12(1):32. PubMed ID: 30947745
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Carcinosarcoma of the ovary.
    Fenn ME; Abell MR
    Am J Obstet Gynecol; 1971 Aug; 110(8):1066-74. PubMed ID: 5284249
    [No Abstract]   [Full Text] [Related]  

  • 18. Serous ovarian carcinoma recurring as a heterologous carcinosarcoma.
    Ferrandina G; Carbone A; Zannoni GF; Martinelli E; Testa AC; Gallotta V; De Ninno M; Scambia G
    J Obstet Gynaecol Res; 2007 Feb; 33(1):95-9. PubMed ID: 17212675
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Carcinosarcoma of the ovary compared to papillary serous ovarian carcinoma: a SEER analysis.
    Rauh-Hain JA; Diver EJ; Clemmer JT; Bradford LS; Clark RM; Growdon WB; Goodman AK; Boruta DM; Schorge JO; del Carmen MG
    Gynecol Oncol; 2013 Oct; 131(1):46-51. PubMed ID: 23906658
    [TBL] [Abstract][Full Text] [Related]  

  • 20. SATB2 Expression Is Sensitive but Not Specific for Osteosarcomatous Components of Gynecologic Tract Carcinosarcomas: A Clinicopathologic Study of 60 Cases.
    Sangoi AR; Kshirsagar M; Horvai AE; Roma AA
    Int J Gynecol Pathol; 2017 Mar; 36(2):140-145. PubMed ID: 27294605
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.